Fig. 1From: Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populationsMutational Landscapes of African and European Ancestry Breast Cancer Patients (AA and EA, respectively). Oncoplots show the top 15 pathogenic mutations in A all patients (AA n = 621, EA n = 2804), B patients with HR+/HER2- disease (AA n = 220, EA n = 1279), and C patients with triple-negative breast cancer (TNBC) (AA n = 143, EA n = 400)Back to article page